PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GH Research PLC (GHRS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

IE000GID8VI0

Sector

Healthcare

IPO Date

Jun 25, 2021

Highlights

Market Cap

$440.16M

EPS (TTM)

-$0.79

Total Revenue (TTM)

$80.00K

Gross Profit (TTM)

-$156.00K

EBITDA (TTM)

-$40.70M

Year Range

$5.08 - $14.99

Target Price

$31.25

Short %

12.89%

Short Ratio

30.57

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
GHRS vs. SEEL
Popular comparisons:
GHRS vs. SEEL

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in GH Research PLC, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
-64.42%
38.55%
GHRS (GH Research PLC)
Benchmark (^GSPC)

Returns By Period

GH Research PLC had a return of 18.10% year-to-date (YTD) and 29.73% in the last 12 months.


GHRS

YTD

18.10%

1M

-37.44%

6M

-41.95%

1Y

29.73%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

24.34%

1M

0.23%

6M

8.53%

1Y

24.95%

5Y*

13.01%

10Y*

11.06%

Monthly Returns

The table below presents the monthly returns of GHRS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202430.86%17.00%20.05%2.81%28.56%-17.25%6.35%-15.32%-36.29%21.08%10.25%18.10%
2023-8.54%7.76%-16.60%5.13%33.33%5.94%10.83%-19.16%-5.46%-27.26%-14.64%-7.05%-40.33%
2022-27.22%-2.83%10.85%-20.39%-31.18%-0.40%11.82%39.34%-25.27%-12.39%7.47%-11.15%-58.34%
202112.88%-9.34%11.02%0.87%14.73%4.58%-11.86%21.19%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of GHRS is 62, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of GHRS is 6262
Overall Rank
The Sharpe Ratio Rank of GHRS is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of GHRS is 6363
Sortino Ratio Rank
The Omega Ratio Rank of GHRS is 6161
Omega Ratio Rank
The Calmar Ratio Rank of GHRS is 6565
Calmar Ratio Rank
The Martin Ratio Rank of GHRS is 6060
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for GH Research PLC (GHRS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for GHRS, currently valued at 0.42, compared to the broader market-4.00-2.000.002.000.422.10
The chart of Sortino ratio for GHRS, currently valued at 1.03, compared to the broader market-4.00-2.000.002.004.001.032.80
The chart of Omega ratio for GHRS, currently valued at 1.13, compared to the broader market0.501.001.502.001.131.39
The chart of Calmar ratio for GHRS, currently valued at 0.35, compared to the broader market0.002.004.006.000.353.09
The chart of Martin ratio for GHRS, currently valued at 1.03, compared to the broader market-5.000.005.0010.0015.0020.0025.001.0313.49
GHRS
^GSPC

The current GH Research PLC Sharpe ratio is 0.42. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of GH Research PLC with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
0.42
2.10
GHRS (GH Research PLC)
Benchmark (^GSPC)

Dividends

Dividend History


GH Research PLC doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-75.45%
-2.62%
GHRS (GH Research PLC)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the GH Research PLC. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the GH Research PLC was 81.15%, occurring on Dec 18, 2023. The portfolio has not yet recovered.

The current GH Research PLC drawdown is 75.45%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.15%Nov 10, 2021529Dec 18, 2023
-40.46%Sep 9, 202131Oct 21, 20216Oct 29, 202137
-26.62%Jul 2, 202117Jul 27, 202129Sep 7, 202146
-6.91%Nov 1, 20212Nov 2, 20215Nov 9, 20217

Volatility

Volatility Chart

The current GH Research PLC volatility is 25.21%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%JulyAugustSeptemberOctoberNovemberDecember
25.21%
3.79%
GHRS (GH Research PLC)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of GH Research PLC over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for GH Research PLC.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab